Cramer's 'Mad Money' Follow-Up: Nov. 11

Every night on "Mad Money," Jim Cramer offers market commentary and general investment advice, and he makes calls on specific stocks, both of his own choosing and in response to viewer requests. He relies on his many years of experience and strong track record, and he takes full responsibility for his calls.

"I never shirk from admitting my mistakes; instead, I dwell on them to learn from them. I change my mind, I take losses, I own up to them," Cramer has said.

Here we track some of his calls from the previous episode of "Mad Money" and find out, at least in the very short term, how the stocks are performing. Keep in mind that Cramer might not have been recommending that viewers take immediate action on a stock. And, of course, it's up to the individual investor to do his or her own homework.

That said, here's how some of the stocks that Cramer talked about on Tuesday's "Mad Money" show fared today.

---

Abbott Labs(ABT Quote): Dan Fitzpatrick saw Abbott breaking out to the upside, and both he and Cramer preferred the company to Johnson & Johnson(JNJ Quote).

On Wednesday, Abbott added 46 cents, or 0.9%, to close at $53.26, while J&J lost 36 cents, or 0.6%, to $60.87.

Herbalife(HLF Quote): Cramer spoke with Chairman and CEO Michael Johnson, who said 80% of Herbalife's sales are international, meaning the company benefits from a weaker dollar. Cramer liked the stock, pointing out its $250 million in cash and zero debt.

Herbalife gained 90 cents, or 2.2%, to $41.80 on Wednesday.

GameStop(GME Quote): Cramer said that the company had no blockbuster games set to debut in the near future and he's not a fan.